Are cystoscopy and urinary cytology sufficient to identify candidates for subsequent biopsy after bacillus Calmette–Guérin treatment in patients with bladder carcinoma in situ?

Dear Editor,Reading the latest European Association of Urology (EAU) guidelines on non-muscle-invasive urothelial carcinoma of the bladder [1,2], as well as the literature, it seems that there are ...